Clinical trials
Coagulation clinical trials
Below are recruiting coagulation clinical trials, each written for real people, not researchers. We’re tracking 71 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07014722Recruiting
Blood clotting study in new central line catheters
This study looks at how blood clotting is activated in new central venous catheters (large IVs placed in a chest vein). It may help doctors understand and reduce clotting risks. You can join if you need a new catheter and are not on strong blood thinners.
Lund, Skåne CountyAges 18 years+ - NCT06432387Recruiting
Blood clotting changes during complex aneurysm repair
This study looks at how blood clotting factors change during a complex aneurysm repair. It may help doctors better understand and manage bleeding risks.
Larissa, ThessalyAges 18 years+ - NCT07742488Recruiting
Statins and hormone therapy for cholesterol in menopause
This study looks at whether taking statins (cholesterol-lowering medicine) along with hormone replacement therapy (HRT) affects blood clotting in women going through menopause who have high cholesterol. It may help doctors understand how these medicines work together.
Pisa, ItalyAges 45–55 - NCT07575295Recruiting
New technique for controlling bleeding during swallowing tube surgery
This trial tests two different methods to prevent bleeding during a minimally invasive procedure (POEM) that treats swallowing problems caused by achalasia or esophageal motility disorders. The study compares a newer underwater technique with the standard approach to see which works better at managing blood vessels during the procedure.
Hyderabad, TelanganaAges 18–65 - NCT07494344Recruiting
Joint replacement surgery study for bleeding disorders
This study looks at how people with inherited bleeding disorders, like hemophilia, do after joint replacement surgery. Researchers want to learn what works best for managing bleeding during and after surgery to improve recovery.
Pavia, LombardyAges 18 years+ - NCT07711743Recruiting
Argon beam coagulation in ovarian endometrioma surgery
This trial studies how deeply argon beam coagulation penetrates ovarian tissue during surgery for endometriomas (ovarian cysts caused by endometriosis). The results may help protect healthy tissue during future surgeries.
Bern, Canton of BernAges 18–40 - NCT05041478Recruiting
Cold removal method for large colon polyps
This trial compares two cold endoscopic techniques to remove certain large, non-cancerous colon polyps with better control of bleeding and leftover tissue. You may be offered one of the two removal methods during your scheduled colonoscopy.
Westmead, New South WalesAges 18 years+ - NCT05645081Recruiting
Blood test study to predict stroke risk after TIA
This trial studies tiny particles in your blood (called extracellular vesicles) to understand and predict stroke risk after a TIA (a temporary stroke-like episode). It may help doctors identify who is at higher risk using blood samples, rather than only symptoms and scans.
Merthyr TydfilAges 18 years+ - NCT05865691Recruiting
Study blood and organ changes in chronic liver disease
This study looks at how blood clotting, inflammation, and blood vessels change in people with chronic liver disease or cirrhosis. Your blood tests may help researchers understand what drives the disease and could guide future care.
ClichyAges 18 years+ - NCT06271941Recruiting
Reducing polyp return after large colon polyp removal
This trial is testing a standard way to remove large polyps from the colon and checking if it helps prevent them from coming back. It's for people who have a large non-cancerous polyp that needs to be taken out during a colonoscopy.
Montreal, QuebecAges 18 years+ - NCT06481995RecruitingPhase 4
Factor XIII for preventing heavy bleeding after childbirth
This study tests whether giving factor XIII, a natural protein that helps blood clot, can reduce excessive bleeding after vaginal delivery. It is for women who are at least 30 weeks pregnant with a single baby and who do not have certain medical conditions.
Geneva, Canton of GenevaAges 18 years+ - NCT06727669Recruiting
Long-term study of blood clotting and bleeding disorders
This study observes patients with blood clotting or bleeding disorders over time to collect health information and improve care.
Beijing, Beijing MunicipalityAges Any age - NCT07073456Recruiting
Blood clotting test for early sepsis detection
This study is testing a new blood test that looks at how well your blood clots to see if it can help find sepsis (a severe response to infection) earlier. It is for adults who might have an infection, but you cannot be taking certain medications or have certain health conditions.
Chaïdári, AtticaAges 18 years+ - NCT07161479Recruiting
Comparing two ways to remove small stomach growths
This study compares two ways to remove tiny, non-cancerous stomach growths—using a gentle heat tool (argon plasma coagulation) or a special scope to cut them out. The goal is to see which method is safer and works better.
Goyang-siAges 20 years+ - NCT07582835RecruitingPhase 3
Long-term heart clot prevention after stent placement
This study tests whether taking a single blood-thinning medication (instead of two) after heart stent placement is safe and effective over the long term. If you've recovered well from a stent procedure, this trial may help determine the safest way to prevent future heart problems.
Lugano, Ch/tiAges 18 years+ - NCT07766135Recruiting
Liver and blood clotting in heart amyloidosis
This study looks at how the liver and blood clotting are affected in people with a type of heart disease called transthyretin amyloidosis. It may help doctors better understand and manage this condition.
Messina, SicilyAges 18 years+ - NCT07416526RecruitingPhase 3
Testing NXT007 for hemophilia A without inhibitors
This study tests a new medicine called NXT007 for people with hemophilia A. It compares NXT007 to standard factor VIII treatment to see if it works better at preventing bleeding episodes.
Aurora, ColoradoAges 12 years+ - NCT06429787Recruiting
Safety study of BALFAXAR vs. Kcentra for urgent blood thinner reversal
This study compares the safety of two medications, BALFAXAR and Kcentra, used to quickly reverse the effects of blood thinners (like warfarin) in people who need urgent surgery or a procedure. It helps doctors understand which option may be safer for patients in this situation.
Boston, MassachusettsAges 18 years+ - NCT02621645RecruitingPhase 4
Early vs late treatment for twin reversed blood flow
This study compares two timing approaches for treating a rare twin complication called twin reversed arterial perfusion (TRAP). It aims to see whether starting treatment earlier or later leads to better baby outcomes and safety for the mother.
Houston, TexasAges 18 years+ - NCT06476145Recruiting
Testing two ways to reduce polyp regrowth after removal
This study looks at two different methods for removing large colon polyps to see which one better prevents polyps from coming back. It may help people who have a non-cancerous, flat polyp that is at least 20 mm wide.
Orlando, FloridaAges 18 years+ - NCT06709833Recruiting
Blood clot risk study for brain tumor patients
This study looks at blood clotting risks in people having surgery for meningioma or glioma brain tumors, and compares them to healthy volunteers. It may help doctors better understand and prevent blood clots after brain tumor surgery.
Tübingen, Baden-WurttembergAges 18 years+ - NCT06410443Recruiting
Steroid treatment for radiation-induced bowel injury
This trial tests if local steroids can help heal bowel damage caused by radiation therapy for cancer. It may reduce pain, bleeding, and urgency, and improve quality of life.
Shenyang, LiaoningAges 18 years+ - NCT07024160RecruitingPhase 1
First-in-human study of MT1011 injection in healthy volunteers
This trial tests a new medicine called MT1011 given as an injection. Researchers want to see how safe it is and how the body handles it. Healthy people can join to help find the right dose for future studies.
Beijing, Beijing MunicipalityAges 18–45 - NCT06379789RecruitingPhase 1/Phase 2
Gene therapy for severe hemophilia B
This trial tests a new gene therapy (REGV131-LNP1265) that aims to let your body produce its own factor IX, reducing or stopping the need for regular infusions. It is for children and adults with severe hemophilia B who are already using factor IX replacement therapy.
Los Angeles, CaliforniaAges 2 years+
Hear when a new Coagulation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for coagulation?
- Yes. Clin2 currently lists 71 recruiting coagulation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a coagulation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a coagulation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.